London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Why call a share down in the 80s,to say you would buy back cheaper if the company is as bad as you say.RYP
Gary RYP I've just been browsing your previous posts where you were ramping to a £1 and then deramping to 40s and 50s when in 80s a bit of constant manipulating by a so called invested person
comments or speechless
Gary (Shelley), like anyone listens to you!
Shelley - Are you not impressed with Colin ?
Oh for crying out loud shelley. Just shut the F*ck up!
All the below is copied from a post on a board that I can not name but I will name because it is a copied post. AVACTA! The poster is a prolific nearly 8k posts poster - PL75!
It is very relevant for here as well. Bighero will give credit where credit is due and he has smallhero status for a day.
“I've previous despaired that my local Labour MP didn't respond to the email I sent inquiring about the new legislation and the free pass being given to Innova and others. The email I sent was the template we had on here (many thanks), with the addition of raising the same concerns for Healgen and highlighting AffiDx performance in identifying the infectious as a green light test.
Some credit is finally due. Today I received a written copy of a letter that she has sent to Sajid Javid where she reiterated the main points from the email/attached links (including the FDA throw them in the trash quote) and has asked him for an urgent response to these Qs:
- Confirm that testing on the Innova tests carried out in accordance with the DHSCs Instructions For Use have taken place?
- Confirm the revised sensitivity rating achieved by the Innova tests when the tests were carried out in accordance with revised DHSC IFU?
- If this testing has not been carried out, please can you confirm what plans you have in place to carry out this testing and when it is due to take place?
She closes her letter by asking:
- Please can you confirm why the government is continuing to invest in Innova Tests for community testing, when there is an opportunity to support British business whilst also providing the community with better quality tests that have been specifically designed for this type of testing?
Obviously, no doubt the govt will spew out the usual dismissive bile, but every little helps.
She's has also forwarded on my email to Sajid and asked me if I have any thoughts on any parliamentary questions that should be raised. Fire away with your ideas - the more the merrier and I'll draft them up and get them sent across....
She noted that whilst the legislation was approved, red flags were raised by the Regulatory Committee and that revisions are due.”